Clinical Trials Browser

Phase 1 × Interventional × Hyperthermia × Clear all

Squamous Cell Carcinoma of Head and Neck, Hyperthermia, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

NCT03749850 2021-02-17

i-GO

Phase 1 Unknown

12 enrolled

Breast

Hyperthermia, Breast Neoplasms, Neoplasm Metastasis, Carcinoma, Ductal, Breast

NCT03547388 2020-05-05

GKH-TMM

Phase 1 Completed

10 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hyperthermia, Hypoxia, Head and Neck Neoplasms, Recurrence

NCT00441376 2019-02-07

A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver

Phase 1 Completed

30 enrolled

Gastrointestinal

Hyperthermia, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT02093871 2017-07-21

PISH-2

Phase 1 Suspended

20 enrolled

Gynecologic

Hyperthermia, Ovarian Neoplasms

NCT00001576 2008-03-04

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Phase 1 Completed

28 enrolled

Gastrointestinal

Hyperthermia, Liver Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT00001577 2008-03-04

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity

Phase 1 Completed

30 enrolled

DermatologicSarcoma

Hyperthermia, Melanoma, Sarcoma

NCT00001587 2008-03-04

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Phase 1 Completed

30 enrolled

Gastrointestinal

Hyperthermia, Liver Neoplasms, Neoplasm Metastasis

Clinical Trials

TANCA-I

i-GO

GKH-TMM

A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver

PISH-2

A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver